fulvestrant has been researched along with Carcinoma in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 12 (40.00) | 29.6817 |
| 2010's | 15 (50.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ashizawa, N; Hosomura, N; Ichikawa, D; Inoue, S; Kawaguchi, Y; Kimura, A; Kono, H; Maruyama, T; Nakada, H; Nakayama, Y; Omori, M | 1 |
| Fredriksson, I; Frisell, J; Haglund, F; Hartman, J; Karthik, GM; Katchy, A; Linder, S; Lövrot, J; Ma, R; Rosin, G; Viberg, L; Williams, C; Zhang, X | 1 |
| Bartlett, CH; Colleoni, M; Cristofanilli, M; DeMichele, A; Giorgetti, C; Huang, X; Im, SA; Liu, Y; Loi, S; Masuda, N; Slamon, DJ; Theall, KP; Turner, NC; Verma, S | 1 |
| Antoon, JW; Beckman, BS; Burow, ME; Collins-Burow, B; David, O; Elliott, S; Lai, R; Martin, EC; Nam, SY; Nephew, KP; Nitzchke, AM; Rhodes, LV; Salvo, VA; Shan, B; Tang, Y; Wang, G; Xiong, W | 1 |
| Kimura-Tsuchiya, R; Saji, S; Sasaki, E | 1 |
| Niraula, S; Ocana, A | 1 |
| Aleskandarany, M; Ball, G; Douglas Macmillan, R; Ellis, IO; Gee, JM; Green, AR; Habashy, HO; Nicholson, RI; Paish, EC; Powe, DG; Rakha, EA; Staka, CM | 1 |
| Grubbs, CJ; Isayeva, T; Johnson, MD; Kern, FG; Mittal, AR; Ponnazhagan, S; Qu, Z; Ramanathan, HN; Thottassery, JV; Westbrook, L | 1 |
| Dumontet, C; Ferlini, C; Matera, EL; Saussede-Aim, J | 1 |
| Barni, S; Gieseking, F; Kaufman, B; Neven, P; Nolè, F; O'Malley, FP; Petruzelka, L; Pritchard, KI; Robertson, JFR; Simon, SD; Steger, GG | 1 |
| Kameda, C; Katano, M; Kubo, M; Nakamura, M; Onishi, H; Tanaka, H; Tanaka, M; Yamasaki, A | 1 |
| Buck, MB; Joffroy, CM; Knabbe, C; Pfizenmaier, K; Popp, SL; Stope, MB | 1 |
| Goldstein, RE; Klinge, CM; Kumar, A | 1 |
| Chung, H; Clarke, R; Mulla, JE; Ning, Y; Riggins, RB; Zwart, A | 1 |
| Blackmore, JK; Foster, EA; Karmakar, S; Smith, CL | 1 |
| Glazer, RI; Kopelovich, L; Lu, J; Yin, Y; Yuan, H | 1 |
| Giulianelli, S; Gutkind, JS; Helguero, L; Lamb, C; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E | 1 |
| Goldberg, GL; Hazan, R; Horwitz, SB; Hou, JY; McDaid, HM; Rodriguez-Gabin, A; Samaraweera, L; Samaweera, L | 1 |
| Belandia, B; Hurst, HC; Orford, RL; Parker, MG | 1 |
| Hall, JM; Korach, KS | 1 |
| Cerbón, M; García-López, P; Mohar-Betancourt, A; Pérez-Cárdenas, E; Rodríguez-Dorantes, M | 1 |
| de Jong, PC; Dingemans, M; Heneweer, M; Muusse, M; Sanderson, JT; van den Berg, M | 1 |
| Kozubík, A; Machala, M; Plísková, M; Vojtesek, B; Vondrácek, J | 1 |
| DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
| Altobelli, G; Biglia, N; Cicatiello, L; Cimino, D; De Bortoli, M; Friard, O; Fuso, L; Ponzone, R; Ravo, M; Scafoglio, C; Sismondi, P; Weisz, A | 1 |
| Chen, G; Tse, G; van Hasselt, C; Vlantis, A; Zeng, Q | 1 |
| Hafner, F; Holler, E; von Angerer, E | 1 |
| Huynh, H; Pollak, M; Yang, XF | 1 |
| Dowsett, M; Ormerod, MG; Zabaglo, L | 1 |
| Kunselman, AR; Legro, RS; Miller, SA; Satyaswaroop, PG | 1 |
1 review(s) available for fulvestrant and Carcinoma
| Article | Year |
|---|---|
Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy.
Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Everolimus; Female; Fulvestrant; Humans; Letrozole; Nitriles; Piperazines; Pyridines; Randomized Controlled Trials as Topic; Trastuzumab; Triazoles | 2016 |
1 trial(s) available for fulvestrant and Carcinoma
| Article | Year |
|---|---|
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease-Free Survival; Double-Blind Method; Drug Resistance, Neoplasm; Estrogens; Female; Follow-Up Studies; Fulvestrant; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Piperazines; Progesterone; Progression-Free Survival; Proportional Hazards Models; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2018 |
28 other study(ies) available for fulvestrant and Carcinoma
| Article | Year |
|---|---|
[Two Cases of Carcinoma en Cuirasse, as Cutaneous Metastasis of Breast Cancer].
Topics: Aged; Breast; Breast Neoplasms; Carcinoma; Female; Fulvestrant; Humans; Skin Neoplasms | 2022 |
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Proliferation; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Gene Knockdown Techniques; Glycolysis; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neoplastic Stem Cells; Phenotype; Pyrazoles; Pyrimidines; Spheroids, Cellular; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Burden; Up-Regulation | 2017 |
MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinogenesis; Carcinoma; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase 5; Mice; Mitogen-Activated Protein Kinase 7; Neoplasms, Experimental; RNA, Small Interfering; Signal Transduction | 2013 |
Molecular diagnostics for precision medicine in breast cancer treatment: what does the future hold?
Topics: Aminopyridines; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Estradiol; Everolimus; Female; Fulvestrant; Humans; Molecular Targeted Therapy; Pathology, Molecular; Piperazines; Precision Medicine; Purines; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; TOR Serine-Threonine Kinases; Trastuzumab | 2016 |
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Topics: Adult; Antigens, CD; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Resistance, Neoplasm; Estradiol; Female; Flavonoids; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Mitogen-Activated Protein Kinases; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Protein Kinase Inhibitors; Receptors, Estrogen; Receptors, Transferrin; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; RNA, Messenger; Tamoxifen; Time Factors; Tissue Array Analysis; Transferrin; Treatment Outcome | 2010 |
High Cks1 expression in transgenic and carcinogen-initiated mammary tumors is not always accompanied by reduction in p27Kip1.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase Inhibitor p27; Drug Resistance, Neoplasm; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Animal; Methylnitrosourea; Mice; Mice, Transgenic; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tumor Cells, Cultured | 2009 |
Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway.
Topics: Breast Neoplasms; Carcinoma; Cell Line, Tumor; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Humans; Promoter Regions, Genetic; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Tamoxifen; Transcription, Genetic; Transfection; Tubulin | 2009 |
Activity of fulvestrant in HER2-overexpressing advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Disease Progression; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Models, Biological; Neoadjuvant Therapy; Receptor, ErbB-2; Retrospective Studies; Treatment Outcome; Up-Regulation | 2010 |
Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer.
Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Signal Transduction; Stomach Neoplasms; Teratogens; Up-Regulation; Veratrum Alkaloids | 2010 |
Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor Modulators; Female; Forkhead Transcription Factors; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immune Tolerance; Tamoxifen; Transforming Growth Factor beta | 2010 |
Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Humans; Phosphorylation; Raloxifene Hydrochloride; RNA, Small Interfering; Signal Transduction; Tamoxifen; Thyroid Neoplasms | 2010 |
IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Caspases; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Interferon Regulatory Factor-1; Interferon-gamma; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT1 Transcription Factor; Tumor Cells, Cultured | 2010 |
Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.
Topics: Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Multigene Family; Nuclear Receptor Coactivator 3; Nuclear Receptor Coactivators; Tamoxifen; Transcriptional Activation | 2011 |
Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anilides; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; Chemoprevention; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Mice; Microarray Analysis; Molecular Targeted Therapy; PPAR gamma | 2012 |
[The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Genes, myc; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Murinae; Progestins; Receptors, Progesterone; Transcription, Genetic | 2012 |
Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.
Topics: Animals; Antineoplastic Agents, Hormonal; Benzamides; Carcinoma; Cell Line, Tumor; Diphenylamine; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Lapatinib; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Ovarian Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |
Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.
Topics: Amino Acid Substitution; Animals; Binding Sites; Carcinoma; Chlorocebus aethiops; Chromosomal Proteins, Non-Histone; COS Cells; DNA Helicases; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation; HeLa Cells; Histone Acetyltransferases; Humans; Macromolecular Substances; Mice; Nuclear Proteins; Nuclear Receptor Coactivator 1; Nuclear Receptor Coactivator 2; Nuclear Receptor Coactivator 3; Promoter Regions, Genetic; Protein Binding; Protein Interaction Mapping; Protein Structure, Tertiary; Receptors, Estrogen; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Two-Hybrid System Techniques | 2002 |
Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Chemokine CXCL12; Chemokines, CXC; Cycloheximide; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Mitogens; Ovarian Neoplasms; Protein Isoforms; Protein Synthesis Inhibitors; Receptors, CXCR4; Receptors, Estrogen; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
Topics: Antineoplastic Agents; Carcinoma; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Flow Cytometry; Formazans; Fulvestrant; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Uterine Cervical Neoplasms | 2004 |
Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
Topics: Aromatase; Aromatase Inhibitors; Benzhydryl Compounds; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Diethylstilbestrol; Drug Synergism; Estradiol; Fadrozole; Female; Fibroblasts; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mammary Glands, Human; Phenols; Prostaglandin-Endoperoxide Synthases; Proteins; RNA, Messenger; Transcription, Genetic; Trefoil Factor-1; Tumor Suppressor Proteins | 2005 |
Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
Topics: Benz(a)Anthracenes; Benzo(a)pyrene; Benzothiazoles; Breast Neoplasms; Bromodeoxyuridine; Carcinogens; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Replication; Dose-Response Relationship, Drug; Drug Interactions; Epigenesis, Genetic; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Thiazoles; Toluene; Tumor Suppressor Protein p53 | 2005 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes.
Topics: Breast Neoplasms; Carcinoma; Down-Regulation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured; Up-Regulation | 2007 |
The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
Topics: Apoptosis Inducing Factor; bcl-2-Associated X Protein; Carcinoma; Carcinoma, Papillary; Cell Death; Cell Proliferation; Cytochromes c; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; Humans; Neoplasm Proteins; Receptors, Estrogen; Subcellular Fractions; Thyroid Neoplasms; Tumor Cells, Cultured | 2008 |
Effect of growth factors on estrogen receptor mediated gene expression.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Reporter; Growth Substances; HeLa Cells; Humans; Insulin; Insulin-Like Growth Factor I; Luciferases; Receptors, Estrogen; Transfection; Tumor Cells, Cultured; Vitellogenins | 1996 |
A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Carcinogens; Carcinoma; Cell Division; Culture Media, Conditioned; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 5; Mammary Neoplasms, Experimental; Oligonucleotides, Antisense; Rats; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1996 |
Measurement of markers for breast cancer in a model system using laser scanning cytometry.
Topics: Apoptosis; Breast Neoplasms; Carcinoma; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Immunohistochemistry; Ki-67 Antigen; Microscopy, Confocal; Microscopy, Fluorescence; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 2000 |
Role of androgens in the growth of endometrial carcinoma: an in vivo animal model.
Topics: Androgens; Animals; Aromatase; Blotting, Western; Carcinoma; Disease Models, Animal; Electrophoresis, Agar Gel; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Regression Analysis; Testosterone; Transplantation, Heterologous | 2001 |